In experiments in rats and mice, two Johns Hopkins
scientists—an engineer and an ophthalmologist—report the successful
use of nanoparticles to deliver gene therapy for blinding eye
disease. A uniquely engineered large molecule allows researchers to
compact large bundles of therapeutic DNA to be delivered into the
cells of the eye.